MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$125K
Net loss
-$5,447K
Total other income
(expenses)
$125K
Loss from operations
-$5,572K
Total operating
expenses
$5,572K
General and
administrative
$3,437K
Research and development
$2,135K
Back
Back
Income Statement
source: myfinsight.com
Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. (KAPA)